Abstract
2389P A multicenter retrospective clinical study: Real-world effectiveness and safety of RC48-ADC alone or combination of RC48-ADC and PD-1 inhibitors for patients with locally advanced or metastatic urothelial carcinoma
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
